Together with many stakeholders in Brussels CropLife Europe – we have 5 points to convey
Whilst we welcome a potential future EU Biotech Act, ambitious and urgent actions are needed today to address bottlenecks that currently hinder investment into innovation, scale up and commercialisation. These immediate actions for biotechnology and biomanufacturing include:
(i) streamline and align regulatory pathways
(ii) ensure access to feedstocks for biomanufacturing
(iii) reflect financing of innovation and scale up, including within EU taxonomy
(iv) improve public understanding and recognition of biotech within a strong future Europe
Button Text